Search | IOVS | ARVO Journals

Showing 1 – 20 of 31

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Development of an injectable, space-filling thermosensitive hydrogel as a subconjunctival bleb scaffold and sustained release drug depot

Jake Armstrong; Richard Zhang; Cindy M L Hutnik

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3150. doi:

ARVO Annual Meeting Abstract July 2018

Assessing the effects of indomethacin and dexamethasone on wound healing using a 3D bioartificial tissue of human Tenon’s capsule fibroblasts

Jim Denstedt; James Armstrong; Cindy ML Hutnik; Charles Trelford

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):479. doi:

ARVO Annual Meeting Abstract July 2018

A Systematic Review and Meta-Analysis of Intravenous Sedation in Modern Cataract Surgery

Efstathia Kiatos; James Jacob Armstrong; Cindy ML Hutnik; Stephen Tsioros; Monali Malvankar; William Hodge

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4778. doi:

ARVO Annual Meeting Abstract July 2018

Acetylsalicylic acid reduces collagen contraction, remodelling and myofibroblast proliferation in subconjunctival tissue mimetic

James Jacob Armstrong; James Denstedt; Cindy ML Hutnik

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2665. doi:

ARVO Annual Meeting Abstract June 2015

Visual Function in Patients with Amyotrophic Lateral Sclerosis

Russell Huang; Joseph Simonett; Nailah Siddique; Jennifer Armstrong; Lisa Kinsley; Teepu Siddique; Nicholas J Volpe; Amani A Fawzi

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):517. doi:

Clinical and Epidemiologic Research July 2013

Methods and Reproducibility of Grading Optimized Digital Color Fundus Photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)

PDF

Ronald P. Danis; Amitha Domalpally; Emily Y. Chew; Traci E. Clemons; Jane Armstrong; John Paul SanGiovanni; Frederick L. Ferris, III
TAGS: color, eye diseases, fundus photography, eye, drusen, diagnostic imaging
Invest. Ophthalmol. Vis. Sci.. 2013; 54(7):4548-4554. doi: https://doi.org/10.1167/iovs.13-11804

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2013

Ocular Manifestations and Optic Nerve Changes in Patients with Amyotrophic Lateral Sclerosis (ALS)

Joseph Simonett; Jonathan Chou; Nailah Siddique; Jennifer Armstrong; Amani Fawzi; Teepu Siddique; Nicholas Volpe

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4382. doi:

ARVO Annual Meeting Abstract April 2010

Evaluation of Age-Related Macular Degeneration Associated Geographic Atrophy From Stereoscopic Color Fundus Photographs and Fundus Autofluorescence Images

C. N. Kruse; A. Domalpally; J. Armstrong; Q. Peng; B. Blodi; R. P. Danis, Jr.; Age-Related Eye Disease Study 2 (AREDS2) ResearchGroup

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1640. doi:

ARVO Annual Meeting Abstract April 2010

Evaluation of Precursors of Geographic Atrophy Associated With Age-Related Macular Degeneneration in the Age-Related Eye Disease Study 2 (AREDS2)

J. R. Armstrong; J. White; A. Domalpally; R. P. Danis, Jr.; B. Blodi; Q. Peng; M. L. Klein; AREDS2 Research group

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):314. doi:

ARVO Annual Meeting Abstract April 2009

Reproducibility of Classification by AREDS Severity Scale and Component Features in AREDS2

R. P. Danis; J. Armstrong; Q. Peng; A. Domalpally; L. Hubbard; AREDS2

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):256. doi:

ARVO Annual Meeting Abstract April 2009

Changes From Baseline to One Year in Fundus Autofluorescence (FAF) Images in the Age-Related Eye Disease Study 2 (AREDS2)

J. R. Armstrong; A. Domalpally; R. P. Danis, Jr.; B. Blodi; Q. Peng; L. Hubbard; AREDS2 Research Group

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):718. doi:

ARVO Annual Meeting Abstract April 2009

Y402H Variant in Complement Factor H (CFH): Association with Age-Related Maculopathy (ARM) and Correlation with Macular Pigment Optical Density (MPOD), Serum C-Reactive Protein (CRP), and Lutein & Zeaxanthin (L&Z) in a Mid-South US Elderly Sample

A. Iannaccone; K. Spencer; L. M. Olson; J. T. Armstrong; K. C. Johnson; E. Kenyon; S. Satterfield; E. J. Johnson; S. B. Kritchevsky; J. L. Haines

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):961. doi:

ARVO Annual Meeting Abstract May 2008

Comparison of Fundus Autofluorescence Images to Digital Color Images for RPE Atrophy in AREDS2

J. R. Armstrong; M. Webster; A. Domalpally; R. Danis, Jr.; B. Blodi; B. Zhang; M. Fleischli; H. Larry; Age-Related Eye Diseases Study 2 Research Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2234. doi:

ARVO Annual Meeting Abstract May 2008

A Pilot Study on the Effect of Lutein and Zeaxanthin Supplementation on Psychophysical and Electrophysiological Macular Outcome Measures

J. T. Armstrong; A. M. Deaton-Cantrell; A. Iannaccone

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4964. doi:

ARVO Annual Meeting Abstract May 2008

Macular Pigment Optical Density, C-Reactive Protein, and Serum Lutein and Zeaxanthin in the Elderly

A. Iannaccone; E. J. Johnson; J. T. Armstrong; E. Kenyon; T. Harris; S. Satterfield; K. C. Johnson; S. B. Kritchevsky

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4965. doi:

ARVO Annual Meeting Abstract May 2007

Macular Pigment Optical Density (MPOD), Serum C-Reactive Protein (CRP), and Serum Lutein and Zeaxanthin (L&Z) in Age-Related Maculopathy (ARM)

A. Iannaccone; E. J. Johnson; K. T. Gallaher; J. Armstrong; E. Kenyon; T. Harris; K.-J. Yeum; S. Satterfield; K. C. Johnson; S. B. Kritchevsky

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):2147. doi:

ARVO Annual Meeting Abstract May 2007

Geographic Atrophy Evaluated From Digital Images: An Extension of the AREDS Classification of AMD

J. R. Armstrong; C. Fink; T. Harding; C. Hurtenbach; B. Zhang; M. Fleischli; R. P. Danis, Jr.; L. D. Hubbard

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):2174. doi:

ARVO Annual Meeting Abstract May 2006

Macular Pigment Optical Density in Age–Related Maculopathy: Findings From the Health ABC Study

K. Gallaher; M. Mura; J. Armstrong; W.A. Todd; S. Satterfield; E. Kenyon; T. Harris; K.C. Johnson; S.B. Kritchevsky; A. Iannaccone

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5668. doi:

ARVO Annual Meeting Abstract May 2006

Ranibizumab (LucentisTM) in Subjects With Predominantly Classic CNV: Reading Center Evaluation of Angiographic Eligibility Characteristics and Baseline Fluorescein Angiographic Data

S.G. Alexander; B.A. Blodi; M.K. W. Webster; J.A. Elledge; C.J. Hiner; J. Armstrong; C.M. Hurtenbach; B. Zhang

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2207. doi:

ARVO Annual Meeting Abstract May 2006

Association of Calcified Drusen With Progression of AMD in AREDS Participants

J.R. Armstrong; L.D. Hubbard; M.D. Davis; R.P. Danis; L.–Y. Lee; B. Zhang; R. Klein; B.E. Klein; AREDS Research Group

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2128. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Development of an injectable, space-filling thermosensitive hydrogel as a subconjunctival bleb scaffold and sustained release drug depot

Assessing the effects of indomethacin and dexamethasone on wound healing using a 3D bioartificial tissue of human Tenon’s capsule fibroblasts

A Systematic Review and Meta-Analysis of Intravenous Sedation in Modern Cataract Surgery

Acetylsalicylic acid reduces collagen contraction, remodelling and myofibroblast proliferation in subconjunctival tissue mimetic

Visual Function in Patients with Amyotrophic Lateral Sclerosis

Methods and Reproducibility of Grading Optimized Digital Color Fundus Photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)

Ocular Manifestations and Optic Nerve Changes in Patients with Amyotrophic Lateral Sclerosis (ALS)

Evaluation of Age-Related Macular Degeneration Associated Geographic Atrophy From Stereoscopic Color Fundus Photographs and Fundus Autofluorescence Images

Evaluation of Precursors of Geographic Atrophy Associated With Age-Related Macular Degeneneration in the Age-Related Eye Disease Study 2 (AREDS2)

Reproducibility of Classification by AREDS Severity Scale and Component Features in AREDS2

Changes From Baseline to One Year in Fundus Autofluorescence (FAF) Images in the Age-Related Eye Disease Study 2 (AREDS2)

Y402H Variant in Complement Factor H (CFH): Association with Age-Related Maculopathy (ARM) and Correlation with Macular Pigment Optical Density (MPOD), Serum C-Reactive Protein (CRP), and Lutein & Zeaxanthin (L&Z) in a Mid-South US Elderly Sample

Comparison of Fundus Autofluorescence Images to Digital Color Images for RPE Atrophy in AREDS2

A Pilot Study on the Effect of Lutein and Zeaxanthin Supplementation on Psychophysical and Electrophysiological Macular Outcome Measures

Macular Pigment Optical Density, C-Reactive Protein, and Serum Lutein and Zeaxanthin in the Elderly

Macular Pigment Optical Density (MPOD), Serum C-Reactive Protein (CRP), and Serum Lutein and Zeaxanthin (L&Z) in Age-Related Maculopathy (ARM)

Geographic Atrophy Evaluated From Digital Images: An Extension of the AREDS Classification of AMD

Macular Pigment Optical Density in Age–Related Maculopathy: Findings From the Health ABC Study

Ranibizumab (LucentisTM) in Subjects With Predominantly Classic CNV: Reading Center Evaluation of Angiographic Eligibility Characteristics and Baseline Fluorescein Angiographic Data

Association of Calcified Drusen With Progression of AMD in AREDS Participants

To View More...

You must be signed into an individual account to use this feature.